ILD in systemic disorders

J-F. Cordier (Lyon, France)

Source: Annual Congress 2007 - PG5 - Interstitial lung diseases: known causes and systemic disorders
Session: PG5 - Interstitial lung diseases: known causes and systemic disorders
Session type: Postgraduate Course
Number: 38
Disease area: Interstitial lung diseases

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J-F. Cordier (Lyon, France). ILD in systemic disorders. Annual Congress 2007 - PG5 - Interstitial lung diseases: known causes and systemic disorders

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Systemic disorders with lung involvement
Source: ERS Course 2018 - Summer school of paediatric respiratory medicine
Year: 2018

COPD as a systemic disease
Source: Annual Congress 2007 - PG6 - COPD: comprehensive clinical assessment and pharmacological and nonpharmacological therapy
Year: 2007



Interstitial lung diseases and systemic disorders with lung involvement
Source: ERS Skills Course 2017 - Summer school of paediatric respiratory medicine
Year: 2017

Interstitial lung diseases and systemic disorders with lung involvement
Source: ERS Skills Course 2016
Year: 2016

Systemic inflammation in patients with COPD and anemia of chronic disease
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019


Interstitial lung disease with ANCA-associated vasculitis (AAV-ILD): Clinical features and survival compared to patients with ILD associated with systemic sclerosis and IPF
Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key
Year: 2020

The relationship between comorbidities and systemic inflammation in patients with COPD
Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases
Year: 2011

Broncho-obstructive syndrome in patients with granulomatous pulmonary diseases.
Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage
Year: 2019

The pulmonary disorders associated with autoimmune pancreatitis
Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases
Year: 2008

Secondary pulmonary hypertension in chronic obstructive pulmonary disease and systemic lupus erythematosus- pathophysiology and treatment
Source: Eur Respir J 2004; 24: Suppl. 48, 59s
Year: 2004

Systemic inflammation and cardiovascular disease in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013


Membrane-receptor disorders in COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 317s
Year: 2004

A study of hematologic disorders in patients with chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease
Year: 2020


Pulmonary hypertension and cardiovascular diseases in ILD
Source: ERS Course 2016
Year: 2016



Pulmonary hypertension and cardiovascular diseases in ILD
Source: ERS Course 2019 - Interstitial Lung Diseases
Year: 2018

Systemic inflammation and pulmonary hypertension in patients with COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 142s
Year: 2007

Systemic inflammation in patients with exacerbated chronic obstructive pulmonary disease (COPD): are anaemia of chronic disease and erythropoietin resistance the missing links?
Source: Annual Congress 2007 - Pathophysiology and assessment of COPD
Year: 2007